FDA

25°

Weather

YnetGlobal Channels

Sites & Sources

more channels

Contact

FDA

Israeli startup QuantalX wins FDA clearance for first-of-its-kind brain function assessment system

The Delphi-MD system, combining magnetic stimulation and EEG, offers real-time, non-invasive brain health insights and sets new US regulatory standard; already in use in Israel and top US research centers, device now being deployed commercially

ynet Global | 11.22.25

Israeli at-home ultrasound tech firm Pulsenmore soars 33% after winning FDA approval

Tel Aviv-based Pulsenmore, developer of the world’s first home ultrasound device for pregnant women, surged 33% after receiving FDA clearance to market its product, paving the way for entry into the American market

Navit Zomer | 11.02.25

Trump administration to link covid shots to child deaths, alarming scientists

Trump officials plan to cite unverified reports tying COVID-19 vaccines to 25 child deaths at a CDC advisory meeting, alarming scientists who warn the shots are safe and protect against severe illness

Ynet Global | 09.12.25

New eye drops approved that restore near vision without reading glasses

The FDA has approved VIZZ, once-daily eye drops that sharpen near vision for millions with age-related presbyopia; Doctors say the treatment reduces side effects seen with earlier drops and could improve quality of life

Tzur Gueta | 08.19.25

Clinical trial finds liver damage in healthy adults taking common CBD doses, often without symptoms; researchers urge regular testing and medical oversight, especially as CBD use grows rapidly despite limited proof of benefits or long-term safety

Tzur Gueta | 07.15.25

US approves at-home cervical cancer test; Israeli pilot programs underway

FDA’s approval of the Teal Wand, a self-sampling HPV test, marks a shift toward accessible cervical cancer screening, with Israeli HMOs piloting similar programs

Tzur Gueta | 05.16.25

שבב להשתלה במוח מתוצרת נוירלינק של אילון מאסק

Cleaning house: Musk fires FDA employees overseeing Neuralink

Cutting comes as part of Musk's U.S. Department of Government Efficiency position aimed at improving processes under Trump's new administration

Oren Rice | 02.18.25

Milk without a cow comes to Israel

Israeli foodtech company Imagindairy, which already has FDA approval, gets go-ahead to market its products in Israel; Company produces protein identical to cow's milk, but without the use of animals, using an environmentally friendly method

Daniela Ginzburg | 11.27.24

Counterfeit diabetes, weight-loss drugs raise alarm after series of fatalities

Reports indicate 10 deaths and over 100 hospitalizations may be linked to counterfeit semaglutide, found in knockoffs of weight-loss drugs like Ozempic; manufacturer warns unregulated versions, not FDA-approved, could endanger public health

Tzur Gueta | 11.09.24

FDA rejects use of MDMA for PTSD

Advisory Committee says it is concerned over allegations of inappropriate sexual behavior during a clinical trial and the potential for severe health risks after taking the drug

News Agencies, Daniel Edelson, New York | 08.11.24

Study reveals presence of toxic metals in tampons

The FDA regulates tampons as medical devices but does not require testing for chemical contaminants

Ynetnews | 07.18.24

Alzheimer drug gets unanimous approval from FDA panel

Lilly's donanemab, Alzheimer's drug benefits outweigh risks in the early stages of the disease although it causes brain swelling and bleeding; the panel finds, clearing the way for a final FDA decision

Reuters | 06.11.24

FDA panel rejects initial MDMA therapy for PTSD

Board criticizes ability of participants to accurately guess if they received MDMA or placebo, potentially skewing results

Ynetnews | 06.05.24

Israeli weight-loss pill stock soars despite detail-free announcement

Israel's Epitomee Medical announced a successful trial for its weight-loss pill; Despite not disclosing the results involving 279 participants, the company's stock rose by 80% at the end of the trading day

Adiel Eithan Mustaki | 09.05.23

FDA approves vaccinating pregnant women against RSV to protect fetus

FDA approves Abrysvo vaccine for pregnant women between weeks 32 and 36 of their pregnancy to protect their unborn child, as the antibodies will provide crucial protection for at least six months – a critical period during which any simple infection can potentially endanger the infant's life

Dr. Itay Gal | 08.23.23